Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Cancer Research

Finasteride and Prostate Cancer: A Commentary

Oncologist

English

Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?

English

Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden

English

Postsurgical Approaches in Low‐Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option?

English

Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast Cancers

English

Cost of Disease Progression in Patients With Metastatic Breast, Lung, and Colorectal Cancer

English

PD‐1 Pandemonium at the American Association for Cancer Research Annual Meeting

English

Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients With Refractory Solid Malignancies: An Interventional Molecular Profiling Study

English

a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination With FOLFIRI for the Second‐Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma

English

Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Cancer Research

Finasteride and Prostate Cancer: A Commentary

Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?

Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden

Postsurgical Approaches in Low‐Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option?

Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast Cancers

Cost of Disease Progression in Patients With Metastatic Breast, Lung, and Colorectal Cancer

PD‐1 Pandemonium at the American Association for Cancer Research Annual Meeting

Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients With Refractory Solid Malignancies: An Interventional Molecular Profiling Study

a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination With FOLFIRI for the Second‐Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma

Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis